Cardioprotective effects of empagliflozin after ischemia and reperfusion in rats

Cardioprotective effects of empagliflozin after ischemia and reperfusion in rats

Abstract The Sodium Glucose Co-Transporter-2 inhibitor, empagliflozin (EMPA), reduces mortality and hospitalisation for heart failure following myocardial infarction irrespective of diabetes status. While the findings suggest an inherent cardioprotective capacity, the mechanism remains unknown. We s...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jacob Marthinsen Seefeldt, Thomas Ravn Lassen, Marie Vognstoft Hjortbak, Nichlas Riise Jespersen, Frederikke Kvist, Jakob Hansen, Hans Erik Bøtker
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/164bc43e8fce4007a2d57ed07fec3e33
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares